Evidence map›Paper›PMID 39482966›Full record

ArticleZhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences2024

[Preparation of decellularized bone graft material with supercritical carbon dioxide extraction technique].

Feng Hao, Kaifeng Pan, Liuyun Huang, Xuhong Chen, Haikun Wei, Xianhua Chen, Jianfeng Zhang

Abstract readEnglish Abstract
In one paragraph

Article in Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Feng HaoZhejiang Decellmatrix Biotech Co., Ltd., Hangzhou 310018, China. hao123feng123@zju.edu.cn.
Kaifeng PanDepartment of Orthopedic Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310016, China. 22118113@zju.edu.cn.
Liuyun HuangZhejiang Decellmatrix Biotech Co., Ltd., Hangzhou 310018, China.
Xuhong ChenZhejiang Decellmatrix Biotech Co., Ltd., Hangzhou 310018, China.
Haikun WeiZhejiang Decellmatrix Biotech Co., Ltd., Hangzhou 310018, China.
Xianhua ChenZhejiang Institute of Medical Device Testing, Hangzhou 310018, China.
Jianfeng ZhangDepartment of Orthopedic Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310016, China. 11018083@zju.edu.cn.

Funding

This work was supported by "Pioneer" and "Leading Goose" R&D Program of Zhejiang 2022C03089
6 · The paper itself

Abstract

objectivesTo evaluate the immunogenicity and osteogenic ability of animal-derived bone graft material decellularized with supercritical carbon dioxide.

methodsPorcine femurs were randomly divided into two groups after preliminary treatment, and decellularized with conventional method (control group) or supercritical carbon dioxide (experimental group). Allogenic demineralized bone matrix was used as positive control. Clearance rate of galactose-α-1, 3-galactose (α-Gal) antigen was determined by enzyme-linked immunosorbent assay and residual DNA was detected by a fluorescence method. Nine SPF-grade male athymic nude mice of 6 weeks old were randomly divided into experimental, control and positive control groups. Samples were implanted over biceps femoris muscle of athymic nude mice. The explants were collected 4 weeks post implantation. Hematoxylin and eosin (HE) staining and immunohistochemistry were applied to determine the osteogenic ability and bone tissue-associated protein expressions of the implants.

resultsThe clearance rates of α-Gal antigen in the experimental group and the control group were (99.09±0.26)% and (30.18±2.02)%, respectively (

conclusionsCompared with clinically used allogenic demineralized bone matrix and bone graft material decellularized with conventional method, bone graft material decellularized with supercritical carbon dioxide exhibits lower immunogenicity and better osteogenic ability.

Indexed as

Bone TransplantationCarbon DioxideMice, NudeAnimalsBone SubstitutesFemurMaleMiceOsteogenesisSwineTissue EngineeringBone SubstitutesCarbon DioxideBone repairDecellularized matrix scaffoldMiceSupercritical carbon dioxideXenotransplantation

Identifiers

PMID39482966
PMCPMC11736345

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.